We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Two Amgen Plants Get 483s For Quality Violations
Two Amgen Plants Get 483s For Quality Violations
August 2, 2013
Amgen’s Longmont, Colo., and Boulder, Colo., facilities received Form 483s for observations that range from inadequate investigations into quality failures to no validation of manufacturing processes.